Evidence Review
Copyright ©The Author(s) 2023.
World J Clin Cases. Apr 6, 2023; 11(10): 2123-2139
Published online Apr 6, 2023. doi: 10.12998/wjcc.v11.i10.2123
Table 1 Coronary hyperemic agents
Agent
Dose
Side effects
AdenosineIntravenous140 µg/kg/min IV; > 40 µg RCA; > 80 µg LCATransient AV block, chest pain, shortness of breath, hypotension, headache, flushing
Intracoronary
Regadenoson400 µg singe bolus central or peripheral IVRhythm or conduction abnormalities, rare gastrointestinal side effects, less frequent chest pain and dyspnea
Papaverine10-12 mg in RCA; 15-20 mg in LCAAbdominal symptoms, headache, flushing of face, increase in heart rate, QTc prolongation, ventricular tachyarrhythmias